Riv Capital Stock Fundamentals
| CNPOF Stock | USD 0.08 0.01 5.68% |
RIV Capital fundamentals help investors to digest information that contributes to RIV Capital's financial success or failures. It also enables traders to predict the movement of RIV Pink Sheet. The fundamental analysis module provides a way to measure RIV Capital's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RIV Capital pink sheet.
RIV |
RIV Capital Company Current Valuation Analysis
RIV Capital's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current RIV Capital Current Valuation | (21.3 M) |
Most of RIV Capital's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RIV Capital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, RIV Capital has a Current Valuation of (21.3 Million). This is 100.15% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 100.13% higher than that of the company.
RIV Capital Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RIV Capital's current stock value. Our valuation model uses many indicators to compare RIV Capital value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RIV Capital competition to find correlations between indicators driving RIV Capital's intrinsic value. More Info.RIV Capital is rated below average in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RIV Capital's earnings, one of the primary drivers of an investment's value.RIV Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RIV Capital's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RIV Capital could also be used in its relative valuation, which is a method of valuing RIV Capital by comparing valuation metrics of similar companies.RIV Capital is currently under evaluation in current valuation category among its peers.
RIV Fundamentals
| Return On Equity | -0.74 | |||
| Return On Asset | -0.0219 | |||
| Operating Margin | (2.72) % | |||
| Current Valuation | (21.3 M) | |||
| Shares Outstanding | 169.13 M | |||
| Shares Owned By Insiders | 19.10 % | |||
| Shares Owned By Institutions | 30.88 % | |||
| Price To Earning | 7.27 X | |||
| Price To Book | 0.23 X | |||
| Price To Sales | 7.93 X | |||
| Revenue | 1.78 M | |||
| Gross Profit | 1.9 M | |||
| EBITDA | (57.77 M) | |||
| Net Income | (52.73 M) | |||
| Cash And Equivalents | 171.54 M | |||
| Cash Per Share | 1.05 X | |||
| Total Debt | 100.45 M | |||
| Debt To Equity | 0.36 % | |||
| Current Ratio | 4.32 X | |||
| Book Value Per Share | 0.92 X | |||
| Cash Flow From Operations | (28.39 M) | |||
| Earnings Per Share | (0.28) X | |||
| Beta | 1.51 | |||
| Market Capitalization | 21.5 M | |||
| Total Asset | 457.62 M | |||
| Net Asset | 457.62 M |
About RIV Capital Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RIV Capital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RIV Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RIV Capital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada. Riv Cap operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in RIV Pink Sheet
RIV Capital financial ratios help investors to determine whether RIV Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RIV with respect to the benefits of owning RIV Capital security.